Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Biomedicines|August 26, 2022
Update on the Pharmacological Treatment of Primary Biliary CholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinInternational Journal of Molecular Sciences|February 24, 2024
Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular CarcinomaAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Review of Gastroenterology & Hepatology|July 30, 2025
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinBiomedicines|July 2, 2021
The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH OxidasesDaniela Gabbia, Luana Cannella, Sara De MartinLife (Basel, Switzerland)|April 27, 2024
Are Gender Differences Important for Autoimmune Liver Diseases?Annarosa Floreani, Daniela Gabbia, Sara De MartinBiomedicines|October 27, 2022
Obeticholic Acid for Primary Biliary CholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Opinion on Investigational Drugs|October 13, 2025
An update on novel investigational agents for the treatment of primary biliary cholangitisAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Review of Gastroenterology & Hepatology|July 29, 2023
Primary biliary cholangitis: primary autoimmune disease or primary secretory defectAnnarosa Floreani, Daniela Gabbia, Sara De MartinExpert Opinion on Drug Metabolism & Toxicology|July 8, 2010
The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an updatePietro Palatini, Rocco Orlando, Sara De MartinCurrent Clinical Pharmacology|August 12, 2008
Enzyme inhibition and induction in liver diseasePietro Palatini, Sara De Martin, Paola Pegoraro, et al.Pageof 10